Business Context and Reporting Period
Company: Healthcare Trust, Inc. (Note: Input metadata referenced "National Healthcare Properties, Inc." but the filing text identifies the registrant as Healthcare Trust, Inc.)
Filing Type: Form 8-K (Current Report)
Date: March 13, 2018
Event: Commencement of a self-tender offer in response to an unsolicited third-party offer.
Key Financial Metrics and Offer Terms
- Company Tender Offer Price: $13.15 per share (Cash, no interest, less applicable taxes).
- Company Tender Offer Size: Up to 2,000,000 shares.
- MacKenzie Offer Price: $12.11 per share (Cash, less distributions paid after Jan 31, 2018).
- Estimated Per-Share NAV: $21.45 (As of December 31, 2016).
- Annual Distribution Rate: Approximately $0.85 per share per year.
- Effective MacKenzie Price: Estimated at no more than $12.04 per share after distribution deductions.
Material Changes and Strategic Actions
The Company initiated a self-tender offer to deter MacKenzie Capital Management, LP (MacKenzie) and other potential bidders from acquiring shares at prices substantially below the Estimated Per-Share NAV. The Board determined the MacKenzie offer price was 44% lower than the NAV. Consequently, the Company suspended its existing Share Repurchase Program (SRP) for the duration of the Company Offer.
Guidance, Outlook, and Management Commentary
- Board Recommendation: The Board recommends that stockholders DO NOT tender their shares in either the Company Offer or the MacKenzie Offer, as both prices are significantly below the current Estimated Per-Share NAV.
- Liquidity Context: The Company acknowledges there is no trading market for the shares and that the Company Offer provides an alternative for stockholders with immediate liquidity needs, offering an 8.6% premium over the MacKenzie price.
- Future NAV Update: The Company expects to publish a new Estimated Per-Share NAV as of December 31, 2017, on or around April 5, 2018. No assurance is given regarding whether this new NAV will be higher or lower than the current $21.45.
- Offer Expiration: The Company Offer expires at 11:59 p.m. Eastern time on April 12, 2018, unless extended or withdrawn.
- Risks: The Board reserves the right to amend, suspend, or terminate the Company Offer. Future distributions are not assured and may change.
Investor Verification Checklist
- Verify the exact terms of the Company Offer in the Offer to Purchase and Letter of Transmittal filed on Schedule TO.
- Confirm the timing and methodology for the upcoming Estimated Per-Share NAV update expected around April 5, 2018.
- Review the suspension status of the Share Repurchase Program (SRP) and its potential future reinstatement.
- Assess the irrevocable nature of tenders under the MacKenzie Offer versus the Company Offer.
- Check for any subsequent filings regarding the extension or termination of either tender offer.